At a glance
ClinicalIndex Comparison RecordN/AUnknown· 678 enrolled
Drug / intervention
CYPHER® ELITE™ Sirolimus-Eluting Stent System +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Single-Blind, Randomized, Multi-Center Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems (ELITE).
In Brief
A clinical study evaluating CYPHER® ELITE™ Sirolimus-Eluting Stent System and CYPHER® Bx VELOCITY® Sirolimus-eluting Stent System for Coronary Artery Disease and Coronary Atherosclerosis. Targeting 678 participants across 1 site.
Detailed Summary
The objective of this study is to show similar (non-inferior) safety and effectiveness between CYPHER® ELITE™ and CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems in a prospective, multi-center, randomized clinical study for the treatment of de novo native coronary lesions.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease, Coronary Atherosclerosis
CountriesUnited States
Collaborators--
Timeline
N/AUnknownOverdue
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2008
First PostedJul 2008
Primary CompletionMar 2010
Study CompletionSep 2014
TodayJul 2026
First PostedJul 15, 2008
Enrollment StartJul 1, 2008
Primary CompletionMar 1, 2010
Study CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 18.0 years ago
Interventions
CYPHER® ELITE™ Sirolimus-Eluting Stent Systemdevice
Drug eluting stent
CYPHER® Bx VELOCITY® Sirolimus-eluting Stent Systemdevice
Drug eluting stent